
BKHAR vs QGEN
$BKHAR vs $QGEN head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
BKHAR vs QGEN: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+9.4%). Split-adjusted daily closes.
- ·Neither kept up with the market over the past year: BKHAR -6.6% and QGEN +5.5%, against the S&P 500 at +9.4%.
- ·QGEN has support 4.2% below at $47.38; BKHAR has no tested support within 35% under its price.
- ·QGEN is within 0.6% of resistance at $49.72, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
BKHAR vs QGEN: the quick read
- ·QGEN is the larger company by market cap ($10.23B vs —).
- ·QGEN has been more active on our scanner (27 vs 1 alerts in 30 days).
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·They trade in different worlds by share price: BKHAR is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·QGEN draws far more of our scanner's attention, 27 unusual-volume alerts in 30 days against 1, so it is the more actively traded of the two by some distance.
- ·QGEN pays a dividend and BKHAR does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: BKHAR is outperforming the other by roughly 7.9 percentage points on the session.
Objective differences only. Not investment advice.
Watching BKHAR or QGEN? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing BKHAR and QGEN on TheDesperateTrader.
- Is BKHAR or QGEN the better stock?
- "Better" depends on your goal, and these two are not alike. QGEN is the larger company by market cap ($10.23B vs —). QGEN has been more active on our scanner (27 vs 1 alerts in 30 days). Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between BKHAR and QGEN?
- The differences that matter: they trade at very different share prices ($1.13 vs $49.44); BKHAR sits at 31% of its 52-week range against 67% for QGEN; only QGEN pays a dividend; our scanner flagged BKHAR 1 times in the last 30 days against 27 for QGEN. Everything above is measured from the latest completed session and SEC filings.
- Which of BKHAR and QGEN is more active right now?
- Right now BKHAR is at about 1.3x its normal volume and QGEN is at about 0.9x, so BKHAR is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is BKHAR or QGEN in the stronger trend?
- BKHAR is below its 50-day average of $1.42; QGEN is above its 50-day average of $47.06 and above its 200-day average of $42.39. QGEN leads 4 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading BKHAR or QGEN? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.